CFO exercised or converted 13K EW derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Apr 9, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Apr 9, 2026
CFOOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001225208-26-004476
- Filed / recorded
Added to OQROOct 2, 2026, 12:27 PM UTC Data qualityVerified: identifiers matched exactly IssuerEdwards Lifesciences Corp Reporting personScott B. Ullem Officer titleCVP, Chief Financial Officer SecurityEmployee Stock Option (Right to Acquire) TableDerivative (Table II) Transaction dateApr 9, 2026 Acquired / disposedDisposed (D) Around the same time
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.